Publications by authors named "Kosuke Doi"

Claim this Profile
L
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2.
Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kosuke Doi

Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world management and outcomes of venous thromboembolism in patients with cancer and limited life expectancy in the direct oral anticoagulant era: insights from the COMMAND VTE Registry-2.
Takahiro Kuno, Norimichi Koitabashi, Yugo Yamashita, Takeshi Morimoto, Yoshiaki Ohyama, Kosuke Doi

Cardiooncology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants　- Insights From the COMMAND VTE Registry-2.
Satoshi Ikeda, Yugo Yamashita, Takeshi Morimoto, Yuki Ueno, Koji Maemura, Kosuke Doi

Circ J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants　- Insights From the COMMAND VTE Registry-2.
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Kosuke Doi

Circ J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry-2.
Tatsunori Noto, Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kosuke Doi

Catheter Cardiovasc Interv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2.
Soichiro Kobayashi, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kosuke Doi

Res Pract Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2.
Yuta Tsujisaka, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Kosuke Doi

J Thromb Thrombolysis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2.
Takahiro Kuno, Norimichi Koitabashi, Yugo Yamashita, Takeshi Morimoto, Yoshiaki Ohyama, Kosuke Doi

Thromb Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism　- From the COMMAND VTE Registry-2.
Shinya Ikeda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Kosuke Doi

Circ J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Wataru Shioyama, Ryuki Chatani, Kosuke Doi

Circulation· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE Registry-2.
Ryo Shigeno, Kitae Kim, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kosuke Doi

Int J Cardiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10-Year Trends of Antithrombotic Therapy Status and Clinical Outcomes in Patients With Atrial Fibrillation and Renal Dysfunction　- The Fushimi AF Registry.
Nobutoyo Masunaga, Mitsuru Ishii, Kouhei Oka, Keita Okamoto, Yusuke Yoshida, Kosuke Doi

Circ J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism　- Insights From the COMMAND VTE Registry-2.
Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Nobutaka Ikeda, Kosuke Doi

Circ J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
Daisuke Sueta, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Kosuke Doi

Thromb Haemost· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2.
Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Kosuke Doi

J Am Heart Assoc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2.
Kensuke Takabayashi, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Kosuke Doi

J Intensive Care· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2.
Toru Sato, Yoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kosuke Doi

Res Pract Thromb Haemost· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2.
Yuji Nishimoto, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Kosuke Doi

J Thromb Haemost· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants.
Ryusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, Kazuhisa Kaneda, Ryuki Chatani, Kosuke Doi

J Am Heart Assoc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2.
Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kosuke Doi

J Thromb Thrombolysis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era.
Kazuhisa Kaneda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Yuji Nishimoto, Kosuke Doi

J Am Heart Assoc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis.
Shinya Ikeda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Kosuke Doi

Thromb Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cAMP-biosensor-based assay for measuring plasma arginine-vasopressin levels.
Kosuke Doi, Kouki Kawakami, Tatsuya Ikuta, Asuka Inoue

Sci Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　- A Predetermined Companion Report From the ONCO PE Trial.
Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Wataru Shioyama, Kosuke Doi

Circ J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of left atrial enlargement with heart failure events in non-valvular atrial fibrillation patients with preserved left ventricular ejection fraction.
Yasuhiro Hamatani, Moritake Iguchi, Keita Okamoto, Yumiko Nakanishi, Kimihito Minami, Kosuke Doi

Eur Heart J Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis